PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+6.43%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.74B
AUM Growth
+$95.7M
(+3.6%)
Cap. Flow
+$27.5M
Cap. Flow
% of AUM
1%
Top 10 Holdings %
Top 10 Hldgs %
40.58%
Holding
1,201
New
69
Increased
381
Reduced
653
Closed
98
Top Buys
| 1 |
Amazon
AMZN
|
+$12.9M |
| 2 |
Palantir
PLTR
|
+$12.2M |
| 3 |
Apple
AAPL
|
+$11.9M |
| 4 |
Microsoft
MSFT
|
+$10.9M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$7.35M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$21.5M |
| 2 |
Meta Platforms (Facebook)
META
|
+$9.51M |
| 3 |
Tesla
TSLA
|
+$3.64M |
| 4 |
Exxon Mobil
XOM
|
+$2.05M |
| 5 |
Chevron
CVX
|
+$1.77M |
Sector Composition
| 1 | Technology | 44.82% |
| 2 | Consumer Discretionary | 12.21% |
| 3 | Communication Services | 10.56% |
| 4 | Healthcare | 9.71% |
| 5 | Financials | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Radian Group
RDN
$4.73B
| $599K | 0.02% |
18,894
+5,501
| +41% | +$174K |
|
427
Viatris
VTRS
$11.9B
| $596K | 0.02% |
47,907
-10,863
| -18% | -$135K |
|
428
Novo Nordisk
NVO
$242B
| $595K | 0.02% |
+6,921
| New | +$595K |
|
429
Travere Therapeutics
TVTX
$2.43B
| $594K | 0.02% |
34,081
+15,181
| +80% | +$264K |
|
430
Prudential Financial
PRU
$37.2B
| $592K | 0.02% |
4,992
-900
| -15% | -$107K |
|
431
First Horizon
FHN
$11.5B
| $591K | 0.02% |
29,354
+3,447
| +13% | +$69.4K |
|
432
Expedia Group
EXPE
$26.7B
| $588K | 0.02% |
3,157
+750
| +31% | +$140K |
|
433
Rhythm Pharmaceuticals
RYTM
$6.66B
| $587K | 0.02% |
10,481
-2,877
| -22% | -$161K |
|
434
Denali Therapeutics
DNLI
$2.14B
| $586K | 0.02% |
28,735
+3,877
| +16% | +$79K |
|
|
SW
435
Smurfit Westrock plc
SW
$23.6B
| $584K | 0.02% |
10,838
-3,050
| -22% | -$164K |
|
436
Glacier Bancorp
GBCI
$5.76B
| $581K | 0.02% |
11,578
+1,929
| +20% | +$96.9K |
|
437
Rambus
RMBS
$8.31B
| $581K | 0.02% |
10,986
-769
| -7% | -$40.6K |
|
438
Williams-Sonoma
WSM
$24.7B
| $579K | 0.02% |
3,129
-578
| -16% | -$107K |
|
439
Jazz Pharmaceuticals
JAZZ
$7.7B
| $575K | 0.02% |
4,671
-1,164
| -20% | -$143K |
|
440
Cummins
CMI
$55.8B
| $575K | 0.02% |
1,650
-108
| -6% | -$37.6K |
|
441
Soleno Therapeutics
SLNO
$3.19B
| $574K | 0.02% |
12,776
+1,580
| +14% | +$71K |
|
442
Pultegroup
PHM
$26.7B
| $574K | 0.02% |
5,270
+1,265
| +32% | +$138K |
|
443
Arrowhead Research
ARWR
$4B
| $573K | 0.02% |
30,495
-9,259
| -23% | -$174K |
|
444
Intellia Therapeutics
NTLA
$1.21B
| $573K | 0.02% |
49,123
-1,229
| -2% | -$14.3K |
|
445
Catalyst Pharmaceutical
CPRX
$2.42B
| $572K | 0.02% |
27,413
-1,705
| -6% | -$35.6K |
|
446
Arcutis Biotherapeutics
ARQT
$2.11B
| $571K | 0.02% |
41,023
-13,559
| -25% | -$189K |
|
447
KeyCorp
KEY
$21.1B
| $570K | 0.02% |
33,277
+5,864
| +21% | +$101K |
|
448
Home BancShares
HOMB
$5.81B
| $570K | 0.02% |
20,143
+4,265
| +27% | +$121K |
|
|
CHX
449
DELISTED
ChampionX
CHX
| $570K | 0.02% |
20,957
-2,453
| -10% | -$66.7K |
|
450
Match Group
MTCH
$9.11B
| $567K | 0.02% |
17,347
+7,148
| +70% | +$234K |
|